ConductScience.org, home

Paper3691593

Nisoldipine in primary Raynaud's phenomenon.

Challenor VF and 5 others. Eur J Clin Pharmacol, 1987. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Nisoldipine in primary Raynaud's phenomenon. Papers, record 3691593. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3691593

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nisoldipine in primary Raynaud's phenomenon.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1987
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.84
iCite
Revised in PubMed
2019-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Challenor VFV F
2Waller DGD G
3Francis DAD A
4Francis JLJ L
5Mani RR
6Roath SS

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Calcium Channel BlockersMajor topic
NifedipineMajor topic
Raynaud DiseaseMajor topic
Vasodilator AgentsMajor topic
Adult
Aged
Drug Evaluation
Drug Tolerance
Erythrocyte Deformability
Female
Humans
Male
Middle Aged
Nisoldipine
Platelet Aggregation

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13089429Managing Raynaud's phenomenon.Br Med J (Clin Res Ed)1986https://conductscience.org/library/papers/3089429PubMed
27194077Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552).Arzneimittelforschung1980https://conductscience.org/library/papers/7194077PubMed
3371334Ca-blockers and peripheral circulation--physiological viewpoints.Acta Pharmacol Toxicol (Copenh)1978https://conductscience.org/library/papers/371334PubMed
4977787A simple method for measuring erythrocyte deformability.J Clin Pathol1976https://conductscience.org/library/papers/977787PubMed
52931096Ex vivo effects of nifedipine, nisoldipine and nitrendipine on filterability of red blood cells from healthy volunteers.Br J Clin Pharmacol1985https://conductscience.org/library/papers/2931096PubMed
66540787Haemorrheological effects of prostaglandin E1 infusion in Raynaud's syndrome.J Clin Pathol1984https://conductscience.org/library/papers/6540787PubMed
76266305Calcium channel blockers and Raynaud's disease.Ann Intern Med1981https://conductscience.org/library/papers/6266305PubMed
83533127Clinical and rheological effects of nifedipine in Raynaud's phenomenon.Br J Clin Pharmacol1986https://conductscience.org/library/papers/3533127PubMed
93723496Nifedipine in the treatment of idiopathic Raynaud's syndrome.J Rheumatol1986https://conductscience.org/library/papers/3723496PubMed
103903157A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.J Rheumatol1985https://conductscience.org/library/papers/3903157PubMed
11552299The two-period cross-over clinical trial.Br J Clin Pharmacol1979https://conductscience.org/library/papers/552299PubMed
123756069Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.Br J Clin Pharmacol1986https://conductscience.org/library/papers/3756069PubMed
132994701Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.Br J Clin Pharmacol1985https://conductscience.org/library/papers/2994701PubMed
144947830The viscosity of human blood plasma; its measurement in health and disease.Biorheology1971https://conductscience.org/library/papers/4947830PubMed
153590105Improved assessment of impedance aggregometry using a microcomputer.Thromb Res1987https://conductscience.org/library/papers/3590105PubMed
163816916Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3816916PubMed
177392654The electronic aggregometer: a novel device for assessing platelet behavior in blood.J Pharmacol Methods1980https://conductscience.org/library/papers/7392654PubMed
183901271The role of platelet calcium.Semin Hematol1985https://conductscience.org/library/papers/3901271PubMed
194388591Metabolic dependence of red cell deformability.J Clin Invest1969https://conductscience.org/library/papers/4388591PubMed
207037872The treatment of severe Raynaud's phenomenon with verapamil.J Clin Pharmacol1982https://conductscience.org/library/papers/7037872PubMed

See all 22 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
29237099Calcium channel blockers for primary and secondary Raynaud's phenomenon.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/29237099PubMed
26914257Calcium channel blockers for primary Raynaud's phenomenon.Cochrane Database Syst Rev2016https://conductscience.org/library/papers/26914257PubMed
10503811Raynaud's phenomenon in older adults: diagnostic considerations and management.Drugs Aging1999https://conductscience.org/library/papers/10503811PubMed
3203045The effect of nisoldipine on whole blood platelet aggregation in patients with Raynaud's phenomenon.Br J Clin Pharmacol1988https://conductscience.org/library/papers/3203045PubMed
3065058
Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
Drugs1988https://conductscience.org/library/papers/3065058PubMed
2663416Management of Raynaud's phenomenon. Focus on newer treatments.Drugs1989https://conductscience.org/library/papers/2663416PubMed
2285650Pathogenesis and treatment of Raynaud's phenomenon.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2285650PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3691593

GET https://conductscience.org/api/papers/v1/3691593/references?page=2